tiprankstipranks
Trending News
More News >
PharmaSGP Holding SE (DE:PSG)
:PSG
Germany Market
Advertisement

PharmaSGP Holding SE (PSG) Ratios

Compare
7 Followers

PharmaSGP Holding SE Ratios

DE:PSG's free cash flow for Q1 2025 was €0.90. For the 2025 fiscal year, DE:PSG's free cash flow was decreased by € and operating cash flow was €0.21. See a summary of the company’s cash flow.
Ratios
TTM
Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio
2.68 2.55 2.26 0.35 1.72
Quick Ratio
2.24 2.14 1.96 0.31 1.48
Cash Ratio
1.32 1.66 1.44 0.22 0.61
Solvency Ratio
0.36 0.28 0.22 0.15 0.83
Operating Cash Flow Ratio
1.00 1.08 1.09 0.13 1.19
Short-Term Operating Cash Flow Coverage
0.00 3.45 3.23 0.14 -5.58
Net Current Asset Value
€ -21.79M€ -28.73M€ -46.50M€ -60.53M€ 8.93M
Leverage Ratios
Debt-to-Assets Ratio
<0.01 0.56 0.07 0.74 0.02
Debt-to-Equity Ratio
0.02 1.86 0.29 3.84 0.03
Debt-to-Capital Ratio
0.02 0.65 0.22 0.79 0.03
Long-Term Debt-to-Capital Ratio
0.00 0.62 0.00 0.00 0.00
Financial Leverage Ratio
3.22 3.30 4.15 5.19 2.17
Debt Service Coverage Ratio
8.93 2.51 2.41 0.17 -4.17
Interest Coverage Ratio
7.65 5.59 8.77 23.98 213.99
Debt to Market Cap
0.00 0.27 0.02 0.29 >-0.01
Interest Debt Per Share
0.39 6.54 0.91 7.15 0.04
Net Debt to EBITDA
-0.72 0.93 -0.87 3.48 -0.52
Profitability Margins
Gross Profit Margin
90.55%90.64%89.48%90.07%90.19%
EBIT Margin
24.55%26.28%20.96%22.72%22.49%
EBITDA Margin
32.30%35.48%31.67%28.30%23.30%
Operating Profit Margin
23.06%24.37%20.50%23.60%25.38%
Pretax Profit Margin
21.53%21.66%18.41%21.74%22.37%
Net Profit Margin
16.14%16.22%13.93%16.36%16.82%
Continuous Operations Profit Margin
16.14%16.22%13.93%16.36%16.82%
Net Income Per EBT
74.94%74.90%75.64%75.25%75.20%
EBT Per EBIT
93.40%88.86%89.81%92.12%88.16%
Return on Assets (ROA)
16.68%12.49%9.26%9.27%42.66%
Return on Equity (ROE)
57.04%41.25%38.44%48.16%92.47%
Return on Capital Employed (ROCE)
29.36%23.09%16.54%68.45%134.76%
Return on Invested Capital (ROIC)
21.89%16.07%11.63%10.77%128.67%
Return on Tangible Assets
32.13%25.13%21.67%32.32%45.91%
Earnings Yield
5.93%6.08%3.74%3.61%3.41%
Efficiency Ratios
Receivables Turnover
7.08 11.00 11.06 10.07 6.72
Payables Turnover
3.05 0.95 1.03 1.44 0.63
Inventory Turnover
1.18 0.94 1.29 1.55 2.04
Fixed Asset Turnover
107.11 85.97 54.56 120.78 83.99
Asset Turnover
1.03 0.77 0.66 0.57 2.54
Working Capital Turnover Ratio
3.59 3.02 -5.46 -2.57 1.22
Cash Conversion Cycle
241.58 40.77 -39.08 17.44 -342.92
Days of Sales Outstanding
51.52 33.18 33.02 36.23 54.31
Days of Inventory Outstanding
309.67 390.27 282.96 235.44 178.56
Days of Payables Outstanding
119.61 382.67 355.06 254.23 575.79
Operating Cycle
361.19 423.44 315.98 271.67 232.87
Cash Flow Ratios
Operating Cash Flow Per Share
1.92 2.22 2.06 1.02 1.29
Free Cash Flow Per Share
1.79 2.15 1.99 -5.93 1.21
CapEx Per Share
0.13 0.07 0.07 6.95 0.07
Free Cash Flow to Operating Cash Flow
0.93 0.97 0.97 -5.82 0.94
Dividend Paid and CapEx Coverage Ratio
1.24 3.95 3.99 0.15 0.16
Capital Expenditure Coverage Ratio
14.48 30.76 31.40 0.15 17.21
Operating Cash Flow Coverage Ratio
25.79 0.36 2.78 0.14 40.26
Operating Cash Flow to Sales Ratio
0.18 0.26 0.29 0.19 0.24
Free Cash Flow Yield
6.23%9.55%7.50%-24.03%4.67%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
16.86 16.46 26.70 27.73 29.32
Price-to-Sales (P/S) Ratio
2.72 2.67 3.72 4.54 4.93
Price-to-Book (P/B) Ratio
9.06 6.79 10.26 13.35 27.11
Price-to-Free Cash Flow (P/FCF) Ratio
16.06 10.47 13.34 -4.16 21.43
Price-to-Operating Cash Flow Ratio
14.98 10.13 12.92 24.22 20.18
Price-to-Earnings Growth (PEG) Ratio
4.05 0.44 2.16 0.00 -0.82
Price-to-Fair Value
9.06 6.79 10.26 13.35 27.11
Enterprise Value Multiple
7.69 8.45 10.87 19.51 20.65
Enterprise Value
303.10M 303.05M 295.44M 360.77M 304.38M
EV to EBITDA
7.69 8.45 10.87 19.51 20.65
EV to Sales
2.48 3.00 3.44 5.52 4.81
EV to Free Cash Flow
14.68 11.76 12.35 -5.07 20.91
EV to Operating Cash Flow
13.67 11.38 11.95 29.47 19.69
Tangible Book Value Per Share
-1.75 -2.19 -3.57 -5.00 0.81
Shareholders’ Equity Per Share
3.18 3.31 2.59 1.85 0.96
Tax and Other Ratios
Effective Tax Rate
0.25 0.25 0.24 0.25 0.25
Revenue Per Share
10.58 8.43 7.15 5.45 5.27
Net Income Per Share
1.71 1.37 1.00 0.89 0.89
Tax Burden
0.75 0.75 0.76 0.75 0.75
Interest Burden
0.88 0.82 0.88 0.96 0.99
Research & Development to Revenue
0.00 0.00 0.00 0.00 0.00
SG&A to Revenue
0.05 0.00 0.00 0.01 0.05
Stock-Based Compensation to Revenue
0.00 0.00 <0.01 <0.01 0.00
Income Quality
1.13 1.62 2.07 1.14 1.45
Currency in EUR
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis